Uncategorized

$SRAX Moving BIGtoken to Separate Company, Announces Malcolm CasSelle as CEO

  • SRAX moving BIGtoken to separate publicly-traded company through definitive share exchange with Force Protection Video Equipment Corp
  • BIGtoken compensates over 16 million users for data which marketers access for fee
  • Malcolm CasSelle appointed CEO of BIGtoken following tenure on SRAX’s board of directors
  • BIGtoken spinoff allows SRAX to focus on rapid growth of Sequire platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, recently announced that BIGtoken, its proprietary platform that empowers Internet users to control and profit from their data, will become a separate publicly-traded company with Malcolm CasSelle as CEO. Spinning off the platform as a separate company is expected to benefit SRAX with potential upsides while reducing costs, enabling the company to focus on Sequire, its highly successful SaaS data analytics platform geared towards the investment industry.

Subject to certain closing conditions, the definitive share exchange agreement between SRAX and Force Protection Video Equipment Corp (NASDAQ: FPVD) is expected to exchange all of the outstanding equity of BIGtoken for 88.9% of the issued and outstanding shares of FPVD. SRAX’s founder and CEO Christopher Miglino will serve as chairman of the new entity and SRAX board member Malcolm CasSelle has been appointed as CEO.

“BIGtoken has experienced wide adoption from some of the largest marketers in the world and is ready to be on its own. This move will allow SRAX to stay laser focused on the rapid growth of the Sequire platform,” said Miglino in recent statements (https://nnw.fm/kCHqV). “Our focus is to get SRAX to profitability, and this move, combined with our significant growth in Sequire, gets us much closer.”

CasSelle brings an extensive range of expertise to BIGtoken, comprised of over 20 years of leadership in several digital media startups, including SVP & GM roles at SeaChange International, a tenure as president at Tribune Publishing, CEO of Timeline Labs, and GM of Groupon’s joint venture with Tencent in China. His seven years on SRAX’s board of directors make him a powerful addition to the executive suite, stemming from experience that spans BIGtoken’s inception straight through to its present-day success.

“I’m thrilled to join BIGtoken as CEO. I’m deeply committed to BIGtoken’s mission and values and believe the company is in a great position to quickly grow its userbase and consequently expand its roster of advertisers,” noted CasSelle (https://nnw.fm/0aNhx). “Our work ahead is promising. BIGtoken is already working with large brands and agencies and we look forward to helping more brands find and engage their target audiences with our platform.”

The BIGtoken platform empowers brands to unlock the power of data by giving them the ability to target and access specific niche groups across 25,000 unique market segments. Over 16 million users provide that data through compensation agreements that reward them with cash or gift cards when they opt in to give access to their data.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $SRAX Moving BIGtoken to Separate Company, Announces Malcolm CasSelle as CEO

$PBIO Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System

  • Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field
  • PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil (e.g., CBD, Vitamins) to be more readily absorbed by human biology
  • Development of th proprietary new instrument – the BaroShear K45-has been proceeding well since the Company received orders for all of its planned initial build of 12 units
  • Pressure BioSciences reported achieving a critical milestone in the production of the BaroDShear K45 units on Oct. 6 with the lock-in of final design specifications for the commercial model and commencement of building the initial “Alpha” model
  • The Company states that once the Alpha model is built, tested and approved, an additional 14 ready-for-sale systems will be built (12 for sale) in time to fulfill plans for shipping the contracted BaroShear K45 Nanoemulsification Systems during early 2021
  • The sale of the first dozen BaroShear K45 units is expected to generate up to $3 million for Pressure BioSciences’ revenue stream in just the first half of 2021
  • Pressure BioSciences expects that the installation of the initial 12 commercial units will propel the sale of significantly more BaroShear K45 units during the second half of 2021 and thereafter

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has achieved another milestone as it nears the initial production of commercial pressure-inducing technology systems expected to revolutionize a wide variety of industries through the nanoemulsification process.

Pressure BioSciences’ proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils so that they become more easily absorbed and effective in the water-based biology of human bodies.

During the weeks before news about the novel COVID-19 virus’ global spread to pandemic levels seized the reins of media coverage, Pressure BioSciences announced it was launching its UST Demonstration Laboratory as a place to showcase the technology’s potential to process cannabidiol (“CBD”) oil into true, high-quality, water-soluble nanoemulsions (https://nnw.fm/5DIAX). Several months later, PBIO announced it had reached sold-out status for its initial rollout of 12 planned BaroShear K45 systems.

On Oct. 6, the Company announced the lock-in of final design specifications for the BaroShear K45’s commercial production model, which immediately launched work on construction of the initial K45 “Alpha” unit. Once the Alpha unit is built, tested and approved, the Company will build an additional 14 units, 12 of which are earmarked as ready-for-sale systems in time for the Company to fulfill plans for shipping them during early 2021 (https://nnw.fm/pNCKb).

“Our commercialization plan for the BaroShear K45 system is initially focused on the rapidly growing hemp-derived CBD market, which is projected to reach $20 billion by 2020,” Director of Marketing and Sales Kenneth F. Micciche stated in the announcement. “We plan to install these (12 BaroShear K45 nanoemulsification) systems during the first half of 2021, which we believe will generate up to $3 million in revenue. Once these initial units are installed and in commercial use, we believe they will propel the close of multiple sales of additional BaroShear K45 systems during the latter half of 2021 and thereafter.”

The Company signed a binding letter of intent to merge with Cannaworx, Inc. (USA) and its portfolio of products and IP in April, which is expected to close shortly (https://nnw.fm/ivFt6). This merger is also expected to bring two additional companies into the new company, which will be known as Availa Bio. These companies are cosmetics industry SkinScience Labs, Inc. (owner of Dr. Denese Skin Care Products, a QVC regular) and cannabis industry Five Leaf Labs, as these additional firms are expected to be signed by Cannaworx under its brand stable once the negotiations are complete.

The UST platform not only processes oils into nanoemulsions that make the oil-based solutions more readily soluble in water, it promotes extended shelf life and/or room temperature stability for low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. It is also expected to improve the fine silky appearance and texture of cosmetic industry products.

Patents have been issued on UST technology in China; PBIO believes that patents should begin to be issued in the United States and in many other parts of the world soon.

For more information, visit the company’s website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $PBIO Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System

$POAI Social Media Could Trigger Secondary Trauma, Depression During Pandemic

Social media was a game-changer when it first came onto the scene. Sites like Facebook and Twitter allowed people to share and connect like they never had, and for a while, no one noticed just how harmful social media could potentially be. But a few years into the social media craze we now know that while it has its benefits, social media can have quite a negative effect on mental health, resulting in anything from depression and anxiety to cyber-bullying and feelings of inadequacy.

According to researchers at Penn State and Jinan University, social media has also caused adverse effects in some individuals during the pandemic. The researchers say that excessive use of social media for updates on the coronavirus pandemic could trigger secondary trauma and depression. “We found that social media use was rewarding up to a point, as it provided informational, emotional and peer support related to COVID-19 health topics,” says Bu Zhong, associate professor of journalism, Penn State.

“However, excessive use of social media led to mental health issues. The results imply that taking a social media break may promote well-being during the pandemic, which is crucial to mitigating mental health harm inflicted by the pandemic,” he says. Zhong describes secondary trauma as behaviors and emotions resulting from knowledge about a traumatizing event experienced by a significant other.

The researchers surveyed 320 participants living in urban districts of Wuhan, China, where the virus was first discovered. In February 2020, they gave the participants an online survey, asking how they accessed and shared health information with family members, friends, and colleagues on social media, specifically on WeChat, the most popular social media mobile app in China. The researchers used an instrument created to measure Facebook addiction to assess the participants’ use of WeChat.

The participants were surveyed using a 5-point Likert-type scale, with the survey assessing their views of WeChat in providing them with informational, emotional, and peer support as well as health behavior changes as a result of social media. More than half of those surveyed reported some level of depression, with nearly 20% of them suffering moderate to severe depression. Additionally, 80% of respondents who reported secondary trauma had a low level of trauma while 13% reported moderate trauma and 7% reported high levels of secondary trauma.

“We found that Wuhan residents obtained tremendous informational and peer support but slightly less emotional support when they accessed and shared health information about COVID on WeChat,” Zhong says. “Our results show that social media usage was related to both depression and secondary trauma during the early part of the COVID-19 outbreak in Wuhan. The findings suggest that taking a social media break from time to time may help improve people’s mental well-being during the COVID-19 pandemic.

While the technology of today is beneficial to medical development, especially when being utilized by companies like Predictive Oncology (NASDAQ: POAI), a precision medicine company that applies data and artificial intelligence (“AI”) to personalized medicine and drug discovery, the rest us of should take a step away from technology from time to time. Moderation is key to enjoying the benefits of modern technology without giving any possible drawbacks chance to manifest.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $POAI Social Media Could Trigger Secondary Trauma, Depression During Pandemic

$NETE Professor Acquires $1M Grant to Develop Superior EV Battery

Most developed countries plan to phase out traditional carbon fuel-powered vehicles for electric vehicles (“EVs”) over the next decade or two. As EVs run on clean, renewable energy, they produce zero emissions, which is in line with the governments’ long term plans to reduce carbon emissions. However, despite being relatively cheaper to fuel (charge) and maintain than traditional vehicles, most of the EVs on the market are way too expensive for the average consumer.

So, even if they wish to switch over to clean energy, a large chunk of the population simply cannot afford it. To make them more affordable, authorities have created programs to subsidize EVs, but Koffi Pierre Yao is going an entirely different way. An assistant professor of mechanical engineering and an alumnus of the University of Delaware, Yao has received a $1 million grant to engineer a next-gen lithium-ion battery that could make electric vehicles a lot more affordable than they are now.

The $1 million grant was from the U.S. Department of Energy’s Advanced Vehicle Technologies Research Program and it will enable Yao and his team to develop a battery that will be able to power electric devices for longer and at a much-reduced cost, a move that could very well revolutionize the energy industry. “If we can make this happen, it will be a paradigm shift. We’ll be taking a game-changing step.”

Traditional lithium-ion batteries, which are used to power EVs, work by converting chemical reactions into electrical energy. Two electrodes built into the battery act as energy carriers and enable this process, a cathode and an anode. The anode is usually made of graphite, and Yao and his team are attempting to make silicon anodes. Since silicon can store and deliver as much as 10 times the energy, this could result in a battery that lasts much longer than current batteries can.

Cell phones will last much longer and electric vehicles would be able to travel even three times the distance on a single charge if these batteries see the light of day. However, Yao and his team have one hurdle to cross: as it stores and releases energy, silicon grows in volume. Compared to a graphite anode which expands by 10%, a silicon anode expands by up to 350%, and this degrades the battery. According to Yao, he can solve the problem if he can create a film that would coat the silicon anode and allow it to expand while preventing degradation. “In layman’s terms, this film will be plastic. It will be elastomeric, meaning it will stretch like rubber.”

“This is a really exciting opportunity,” says Rownak Jahan Mou, a graduate student who is part of Yao’s team. “If we are successful with the silicon coating, this could open the door for still other materials to use, and even more battery options.”

This kind of next-generation thinking is the type of innovation that aligns with companies like Net Element (NASDAQ: NETE).

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $NETE Professor Acquires $1M Grant to Develop Superior EV Battery

$ICLK Expands Stake in Changyi, Further Positions to Continually Enhance Smart Solutions

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has increased its controlling interest in Changyi (Shanghai) Information Technology Co. Ltd. Changyi is a leading independent software vendor that provides intelligent retail and CRM solutions, through which iClick has further enhanced its data-driven Enterprise Solutions business. “Our clients are continually looking for ways to increase operational and marketing efficiencies as they tackle the challenges of doing business in China and the region,” iClick co-founder and CEO Jian “T.J.” Tang said in the news release. “Through expanding our stake in Changyi, we will be better positioned to continually enhance our existing Enterprise SaaS solutions and advanced omni-channel automated marketing data services allowing us to effectively address the demand that we are seeing.”

To view the full press release, visit http://nnw.fm/j3F20

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide, including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://nnw.fm/ICLK

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $ICLK Expands Stake in Changyi, Further Positions to Continually Enhance Smart Solutions

$CNSP Highlights New Glioblastoma-Focused Segment Airing on Lifetime TV

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today highlighted a new segment from The Balancing Act titled, “Behind the Mystery,” which will air on Lifetime TV and focus on glioblastoma. The segment, live this morning, follows the unique story of a glioblastoma patient and clinical insights regarding the rare and difficult-to-treat disease from Dr. Sigmund Hsu, a member of CNS Pharmaceuticals’ Scientific Advisory Board. In addition, a re-airing of the segment is planned for October 23, 2020. “It is encouraging to see The Balancing Act bring awareness to such a devastating disease. Glioblastoma is one of the most aggressive primary brain cancers in adults, with approximately 13,000 new patients diagnosed each year in the U.S.—the highest diagnosis rate of all malignant brain tumors,” CNS Pharmaceuticals CEO John Climaco said in the news release. “At CNS, we are committed to our development efforts in glioblastoma.”

To view the segment and hear the story, visit https://ibn.fm/Jfqk6

To view the full article, visit http://ibn.fm/l7K8c

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006.  In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland.  Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, October 12th, 2020 Uncategorized Comments Off on $CNSP Highlights New Glioblastoma-Focused Segment Airing on Lifetime TV

Cybin Corp. Holds Distinct Strength in Psychedelics Space

Cybin Corp., a Canada-based, life-science company, is focused on the development of mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products. The company is positioning as countries around the world become increasingly accepting of psilocybin’s use in controlled settings and recent clinical studies unveil its potential in treating mental health disorders and other conditions. A recent article discussing the company’s pioneering efforts on this front reads, “Cybin already holds a unique strength in the psychedelics space. The company is responsible for some of the first published research on microdosing; i.e, the action or practice of taking or administering very small amounts of a drug to test or benefit from its physiological action while minimizing its potentially undesirable side effects. Microdosing sub-hallucinogenic amounts of psychedelic drugs including psilocybin has several potentially positive indications. As such, Cybin is ideally positioned to leverage the growing acceptance of psilocybin in mainstream space.”

To view the full article, visit https://nnw.fm/rgpgM

About Cybin Corp.

Cybin is a mushroom life-science company advancing psychedelic and nutraceutical-based products. The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the company is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships. For more information, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://nnw.fm/Cybin

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Monday, October 12th, 2020 Uncategorized Comments Off on Cybin Corp. Holds Distinct Strength in Psychedelics Space

$SGTM Announces Series of New Partnerships and Contract Renewals

  • Sustainable Green Team Ltd. announced series of new partnerships for its subsidiaries
  • National Storm Recovery stated that it had entered into an alliance with Tree Leads Today to source contracts outside of their traditional geographical coverage area
  • Mulch Manufacturing Inc., SGTM’s wholly-owned mulch producing subsidiary, announced that it had renewed its agreement to supply mulch products to home-improvement chain, Menards Inc.

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has recently updated the market on the significant progress achieved by its subsidiaries, as both National Storm Recovery LLC and Mulch Manufacturing Inc. announced new partnership agreements.

National Storm Recovery LLC announced that it had formed a strategic alliance with Tree Leads Today to expand their national partnerships in a bid to obtain contracts currently outside of their geographic sphere of activity (https://nnw.fm/Mvn3p). The strategic alliance was formed when National Storm Recovery deployed its teams to assess damages from Hurricane Laura, with Tree Leads Today helping the Company partner with ArborPro of Mississippi Inc. on a recovery contract awarded for recovery work carried out in the city of Sulphur, Louisiana.

Tree Leads Today is a privately held company with a nationwide footprint. The company is focused on providing tree companies with leads on tree care projects and services. The process of generating leads is done strategically so that leads are as close to one another as possible in order to maximize productivity for TLT’s tree care partners when they are giving estimates and completing contracted jobs.

“We are honored to be partnering with such an innovative and environmentally conscious organization as Sustainable Green Team,” commented Tree Leads Today CEO Don Dowd. “Tree Leads Today believes in a pay-for-performance model. We believe in our offerings so much that we take all of the risks and only expect you to pay if we deliver.”

“This strategic alliance will amplify our national partnerships and, most importantly, increase recovery contracts far beyond our reach through our Central Florida Arbor Care subsidiary,” said SGTM CEO and director Tony Raynor. “Our new strategic alliance with Tree Leads Today removes all of our limits, opening many new opportunities for our brand, team and shareholders.”

Simultaneously, SGTM has also announced that its wholly owned subsidiary, Mulch Manufacturing Inc. (“MMI”) has been awarded a 2021 mulch packaging contract renewal from Menards Inc.

Menards operates the third-largest home improvement chain in the U.S., managing 350 stores spread across 15 states. Mulch Manufacturing Inc. has been supplying Menards with mulch products dating back to 2010, with the current contract renewal dictating that Menards would increase the number of its stores carrying MMI’s mulch products by 25% over the course of the next calendar year.

SGTM’s CEO and Director Tony Raynor commented in relation to the news, “Menards mulch packaging contract renewal brings me great pride on team and the direction we’re headed. I’m a firm believer that you’re only as strong as your team, and SGTM’s achievements and trajectory validates it.”

To learn more, view the company’s investor presentation at http://nnw.fm/UpXmd

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://nnw.fm/SGTM

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $SGTM Announces Series of New Partnerships and Contract Renewals

$PCSA Featured in Simply Wall St Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA Co-Founder Patrick Lin’s recent stock purchase at near current price. The article reads, “Potential Processa Pharmaceuticals Inc. (NASDAQ: PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share. While that’s a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 8.5%. In fact, the recent purchase by Patrick Lin was the biggest purchase of Processa Pharmaceuticals shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of US$4.08. . . . While we always like to see insider buying, it’s less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. Happily, the Processa Pharmaceuticals insiders decided to buy shares at close to current prices.”

To view Simply Wall St’s latest analysis for Processa Pharmaceuticals, visit https://ibn.fm/FRRP9

To view the full article, visit: https://ibn.fm/IXeAR

About Processa Pharmaceuticals Inc.

The mission of Processa has been to develop products where existing clinical evidence of efficacy already exists in unmet medical need conditions — medical conditions where patients need treatment options that will improve survival and/or quality of life. The company has assembled a proven regulatory science development team, management team and board of directors. The Processa development team has been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and 100 FDA meetings. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at http://ibn.fm/PCSA

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $PCSA Featured in Simply Wall St Article

$POAI Early Morning Coffee Could Impair Metabolism, New Research Suggests

October 1st was International Coffee Day, and it is estimated that half of all U.S. adults consume coffee on a daily basis. You might therefore be no stranger to taking a strong cup of coffee each time you wake up feeling groggy. But, did you know that the early morning cup of strong coffee you take could be compromising your metabolism and making it harder for your blood glucose level to be regulated? New research done at the University of Bath (UK) strongly suggests that this is the case.

The research team headed by Harry Smith performed overnight experiments on 29 men and women. In one of the experiments, the study participants were asked to sleep as they normally do at night, and then consume a sugary drink just after they woke up.

In another experiment, the study participants were woken up every hour for five minutes to simulate a disturbed night’s sleep. Upon waking up in the morning, these subjects were also given a sugary drink identical to the one of the group that didn’t have their sleep disturbed.

In a third experiment, the participants also had their sleep disrupted on an hourly basis. However, this group got a strong cup of coffee upon waking up, and then received the sugary drink half an hour later.

For each of these experiments, blood samples were drawn from the study subjects after they took the sugary drink. When these samples were analyzed, it was found that taking a strong cup of coffee before you have your breakfast can compromise your body’s ability to regulate blood glucose by at least 50%. This conclusion came after the researchers noted that the participants who took coffee 30 minutes before the sugary drink had 50% more blood glucose than what was found in the experiments in which the participants didn’t take coffee before having the sugary drink.

This surprising discovery suggests that it might be better to have your breakfast first before taking your customary cup (or cups) of coffee to perk you up in the morning.

On a more positive note, the researchers found that contrary to what was previously believed, a single night of disrupted sleep, such as when insomnia strikes or you get a new baby, isn’t sufficient to compromise your metabolism.

There is need for additional research to be done on the long-term effects of sleep disruption upon our metabolism, and to what extent exercise can counter some of those effects. While it may be hard for us ordinary mortals to adjust to such research which suggests we have been doing certain things wrong all our lives, research-heavy entities like Predictive Oncology (NASDAQ: POAI) see such groundbreaking findings as a normal part of learning.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $POAI Early Morning Coffee Could Impair Metabolism, New Research Suggests

$NETE Looks to Compelling Opportunity Through Pending Reverse-Merger

Net Element (NASDAQ: NETE) previously entered a definitive agreement to merge with Mullen Technologies, a Southern California-based electric vehicle (“EV”) company, in a move intended to maximize shareholder value. The pending reverse-merger will allow privately-held Mullen stakeholders to acquire a majority of the new stock and accelerate the process of taking the company public, giving potential investors an opportunity to purchase relatively undervalued shares within the rapidly growing sector. Investors continue to divert capital into the EV industry, pushing EV stock prices to unprecedented levels. “We feel, after considering an array of strategic alternatives, that the agreement with Mullen provides our shareholders with the most compelling opportunity,” stated Net Element chairman and CEO Oleg Firer in a recent article discussing the move. “We conducted an extensive search of companies that have disruptive technologies and believe that Mullen represents the best path forward.”

To view the full article, visit https://ibn.fm/5IAsc

About Net Element Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017 Net Element was recognized by “South Florida Business Journal” as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $NETE Looks to Compelling Opportunity Through Pending Reverse-Merger

$CNSP Research Identifies Two Types of Parkinson’s Disease

For long, doctors and researchers have been baffled by the myriad of different symptoms that people with Parkinson’s disease exhibit. According to new research that has just been published in a neurological journal called Brain, it now turns out that Parkinson’s is not just a single disease. Rather, the condition has two variants which should be managed differently.

This eye-opening research was done by a team from Aarhus University Hospital and Aarhus University in Denmark. Professor Per Borghammer and Jacob Horsager, M.D. are the researchers behind this work.

The team used advanced brain scanning techniques (PET and fMRI) to establish that Parkinson’s can originate from two different parts of the body, and that explains why the symptoms manifesting in sufferers differ.

Their research revealed that some cases of Parkinson’s start within the intestines and then spread to the other organs of the body, such as the brain. This variant was named the body-first type of Parkinson’s since the neural degeneration starts in the intestines before spreading to the neurons in the brain.

The second variant of Parkinson’s that the researchers found is the brain-first variant. The scans showed that this variant is harder to detect because no symptoms are evident until extensive damage has occurred to the neurons in the brain and the condition has spread to the rest of the body. It is therefore harder to slow down the progression of this brain-first disease.

Previous research had indicated that patients with Parkinson’s had gut microorganisms (microbiota) that differed from that of other people. However, it wasn’t clear why this difference existed. The research done by Prof. Per Borghammer and his colleague was designed to get answers explaining this difference in gut microbiota.

Their research was designed as a longitudinal study. This means that the researchers will call back their study subjects after three years have elapsed, and later at the six-year mark in order to run all the tests and scans which were done during the initial stages of the study. This study design is meant to collect comprehensive information about Parkinson’s disease (or diseases).

The research and its findings offers hope to the millions of people suffering from Parkinson’s that interventions could in future be more targeted so that the people suffering from either brain-first or body-first variants of the disease get appropriate treatment.

For example, the scientific community could look into fecal transplantation in order to slow down or even reverse body-first Parkinson’s in its initial stages when altering the intestinal microbiota can be beneficial. There is no doubt that entities like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) will immediately appreciate the utility of the findings of this Danish pair of researchers.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $CNSP Research Identifies Two Types of Parkinson’s Disease

$CNSP Begins Manufacturing of Lead Drug Candidate in Europe

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (“GBM”). GBM is an aggressive form of brain cancer currently considered incurable. “Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” CNS Pharmaceuticals CEO John Climaco said in the news release. “With the manufacturing of our Berubicin Drug Product in Europe, we continue to advance closer toward an IND filing for Berubicin, which we expect to submit later this quarter. We have also made significant progress on the clinical front and recently engaged Worldwide Clinical Trials as the contract research organization, Image Analysis Group (‘IAG’) as the imaging partner, and Berry Consultants as a biostatistical advisor for our Phase 2 trial design. We have also added Dr. Patrick Wen, a renowned neuro-oncologist, to our Scientific Advisory Board. Our laser focus remains on initiating a U.S. Phase 2 trial for Berubicin in Q1 of 2021 and we continue to demonstrate our ability to execute our operational and clinical plans toward that goal.”

To view the full article, visit: https://ibn.fm/bvtlq

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006.  In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland.  Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $CNSP Begins Manufacturing of Lead Drug Candidate in Europe

$CNPOF Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products combining hemp seed oil, organic plant oils, essential vitamins, antioxidants, and bioflavonoids; and Headset Inc. launched its competitive intelligence tool, Headset Insights Pulse, in Massachusetts.

To view the full press release, visit http://cnw.fm/droX2

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on $CNPOF Provides Update on Portfolio Expansion in the US

Rritual Mushrooms Inc. Launches Production of Premium Suite of Functional Elixirs

  • This is the company’s first line of premium products to be introduced into the market, and will be primarily distributed in countries with the highest demand for functional and medicinal mushroom superfood products – the U.S., Canada, and Japan
  • The company is working with select retailers for an imminent strategic launch date.
  • The company is set to launch a premium and user-friendly shopping experience through it’s e-commerce website
  • The functional mushroom industry’s current demand is forecasted to $34 billion by 2024, with a global market expected to reach $50 billion by 2025
  • The market has no clear brand leader at the moment, but Rritual is intent to capitalize on its innovative product line to take this position
  • Company’s current marketing plan can help achieve this goal by simplifying operations and promoting business growth with a reduced time to market

Rritual Mushrooms is emerging as a premium, leading brand in the functional food and mushroom market following the launch of its innovative suite of premium functional mushroom and adaptogenic elixirs this fall. “The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research. Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects,” said Dr. Mike Hart, President of Rritual, who also oversaw the development of the new line of products (https://nnw.fm/gdqVJ).

The premium suite of products consists of three different formulas made from the company’s proprietary blend of adaptogenic herbs and organic mushrooms: Reishi Relax, Chaga Immune, and Lion’s Mane Focus.

Developed for stress support, balancing mood, and facilitating restful sleep, the Reishi Relax blend is infused with cacao, ashwagandha root, and cinnamon to provide optimal wellness. Chaga Immune, also featuring Atragulus and the proprietary immune blend created by Rritual, works to enhance immune health and strengthen the body’s stress defenses. Lion’s Mane Focus was developed for cognitive health and enhanced memory and creativity, offering a mental boost as a result of its composition that includes Rhodiola root and Ayurvedic herbs like Bacopa.

Upon release, these premium products will be available through the Rritual website and the Rritual Amazon store. Each elixir will come in a 14 stick pack or 250-gram tub. A combo pack will also be available featuring all three elixir sticks in a 14 count pack.

Rritual’s premium products are the first premium brands to hit the functional mushroom market, a fast-growing sector where demand is growing and is forecasted to rise to $34 billion by 2024. As of right now, there is no clear leader in the industry, but Rritual may take this position with the release of its new products. Globally the market for functional mushrooms is expected to reach $50 billion by 2025. The current marketing structure of Rritual shows the plan to deliver its products to the United States, Canada, and Japan, countries with the highest demand for functional and medicinal mushroom superfood products.

Since its launch in 2019, Rritual’s sole purpose has been to help every person meet the demands within their life with style and ease through mushroom adaptogens. All products are plant-based and vegan, without the use of artificial sweeteners or fillers. Each product produced by Rritual is made with the principle of creating a product with limited, yet purposeful organic ingredients.

Rritual is currently working on two different marketing strategies – e-commerce and brick and mortar. Each of these strategies will be completed in two phases. The fall release is stage one of the e-commerce strategy currently underway. The second stage of the e-commerce strategy is to use team connections to create a direct-to-consumer experience using mediums such as Costco, CVS Pharmacy, Walmart, and Vitacost.

In stage one, the brick and mortar strategy will see the launch of the premium products in four non-competing store chains that have a shared best practice agreement. The stage two plan expands upon the first, but expansion will include 11 more retailers selling the product in a set number of their stores.

The “low hanging fruit” strategy and turnkey, global services market, will significantly lower the time it will take for Rritual’s products to find their way into a leading position within the industry. These strategies also simplify operations and support the company’s scaling efforts, helping it enhance its visibility on a market waiting for a leader.

For more information, visit the company’s website at www.WeAreRritual.com. 

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at https://nnw.fm/Rritual

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, October 9th, 2020 Uncategorized Comments Off on Rritual Mushrooms Inc. Launches Production of Premium Suite of Functional Elixirs

$UUUU Rare Earth Elements: Why the US Shouldn’t Panic Just Yet

Statistics show that the U.S. gets 80% of its rare earth elements from China, and now that there is tension with China, there are fears that the Asian country could “weaponize” rare earth elements in its trade war with the U.S. by cutting off supplies to starve U.S. industries that need these elements. The industries in which rare earths are used include medical devices, advanced weapons systems, wind and solar energy, electric vehicle making and so many others. However, there is no need for panic regarding the Chinese dominance of the supply chains of rare earth elements, and here is why.

Local Production Can Be Ramped Up

The name “rare earth elements” often misleads people into thinking that it is hard to find these products in the earth. However, this isn’t true because rare earths are quite common. The only challenge is that they occur hidden in other ores, and complex as well as costly processes have to be performed to extract and purity these rare earths.

At the moment, China has the biggest number of purification facilities for rare earths, but a mine for these elements exists at Mountain Pass in California. If China cuts supplies, the owner of this mine would simply ramp up production and keep U.S. industries operational.

Sourcing Can Be Obtained Elsewhere

In the event that China restricted rare earths exports to the U.S., manufacturers can turn to suppliers elsewhere to address their needs. For example, Australia has one of the largest rare earth elements processing facilities outside China, and they can step up production quickly to meet the increased demand.

Existing Mining Companies Can Pivot to Rare Earths

When supply is low and demand is high enough, it is possible for existing mining companies to expand their operations and start separating rare earths from the waste currently generated by their operations.

Industries Can Tweak Their Rare Earths Needs

If push comes to shove, industries that use rare earth elements could be forced to look for ways to eliminate or reduce the quantity of rare earths that they use. This reaction isn’t unprecedented, as Japan automakers developed hybrid car motors which did away with or reduced the need for rare earth elements after China cut its exports to Japan in 2010. Oil refineries also reduced their rare earths needs during that scare, and so did glassmakers. This therefore goes to show that innovation can respond to supply shortages and come up with alternatives in the face of rare earths supply shortages instigated by China’s trade war with the U.S.

As you can see, there will be no doom and gloom if China decided to cut off supplies of rare earth elements to the U.S. Lots of options exist, and a lot of good could actually result from China restricting exports to the U.S.! This is probably the same view that is held by mining entities like Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR).

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, October 8th, 2020 Uncategorized Comments Off on $UUUU Rare Earth Elements: Why the US Shouldn’t Panic Just Yet

$MEDS Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, assists pharmacies in cutting costs in an era where the pricing of medication poses a major challenge that significantly inflates health-care spending. Trxade’s pharmaceutical trading platform is designed to reduce costs, assisting smaller pharmacies to compete through providing radical price transparency and increased market competition. A recent article discussing this reads, “The online marketplace hosted by the Trxade Group offers pharmacies a real opportunity to reduce purchase costs. Called the Trxade¿Exchange, the platform gives small pharmacies access to the wider pharmaceutical distribution network, allowing them to search for and view products from manufacturers, buying groups¿and wholesalers on a real-time and continuous basis. By increasing competition and price transparency, the Trxade¿Exchange is giving today’s independent drugstores a new lease on life.”

To view the full article, visit: https://nnw.fm/4y832

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and health-care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health-care services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: (1) the Trxade B2B trading platform with 11,725 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail-order delivery. For additional information, please visit www.Trxade.comwww.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Thursday, October 8th, 2020 Uncategorized Comments Off on $MEDS Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs

$VTGN Featured in Research Report

VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent research report by Aegis Capital Corp. The report reads, “VistaGen is developing multiple therapeutic candidates for the treatment of anxiety, depression, and other CNS indications. VistaGen’s development pipeline includes PH94B, a neuroactive nasal spray targeting Social Anxiety Disorder (‘SAD’), among other conditions, PH10, an additional neuroactive nasal spray for indications including Major Depressive Disorder (‘MDD’), and AV-101 an oral drug for psychiatric and other CNS disorders. We believe Phase 2 data in PH94B and PH10 strongly supports proof of concept, including compelling safety and efficacy data that likely differentiate these assets from existing treatments in crucial ways that could be supportive of market adoption if and when approved.”

To view the full report, visit http://ibn.fm/eLamD

About VistaGen Therapeutics

VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, October 8th, 2020 Uncategorized Comments Off on $VTGN Featured in Research Report

$VTGN Seasonal Colds Could Offer Protection Against COVID-19

Months after the coronavirus sprang onto the global arena and claimed a million lives worldwide, scientists are still scrambling to find a vaccine and ultimately, a cure. At the moment, there are around 40 different coronavirus vaccines in clinical trials, with about 240 vaccines in early development. One such study suggests that we may not even need an external vaccine after all and provides evidence that the seasonal colds you’ve had in the past could offer you protection against COVID-19.

On top of that, such immunity to the coronavirus may last a long time, maybe even your entire life, infectious disease experts at the University of Rochester Medical Center say. The study compared blood samples from two groups: 26 people who were recovering from mild to moderate coronavirus and 21 healthy donors whose samples were collected 6 to 10 years ago, long before they could have been infected by COVID-19.

The researchers measured levels of memory B cells, immune cells that can detect pathogens, create antibodies to destroy them, and remember them for the future. The study, published in mBio, found that SARS-CoV-2, the virus that causes COVID-19, induces memory B cells which can live for decades. Most common coronaviruses result in upper respiratory illnesses, and they each trigger memory B cells into action.

The authors of the study believe that this could mean anyone who has been infected by a common coronavirus, which is almost everyone, may develop some degree of immunity to the coronavirus. “When we looked at blood samples from people who were recovering from COVID-19, it looked like many of them had a pre-existing pool of memory B cells that could recognize SARS-CoV-2 and rapidly produce antibodies that could attack it,” says lead study author Mark Sangster, Ph.D., a research professor of Microbiology and Immunology at URMC.

This is the first study to report cross-reactivity of memory B cells, meaning memory B cells that once neutralized cold-causing coronaviruses recognizing SARS-CoV-2 and springing into action. The cells produce antibodies that attack specific parts of the Spike Protein, a key protein used by the coronavirus to invade human cells. Although the Spike Protein looks and acts a little different in each coronavirus, one of its components dubbed the S2 subunit is the same across all the viruses.

The study found that in beta coronaviruses, a subclass that includes SARS, MERS, SARS-CoV-2 as well as two common colds, memory B cells can’t tell the difference between the Spike S2 subunits of different coronaviruses and attacks indiscriminately.

According to David Topham, PhD., the Marie Curran Wilson and Joseph Chamberlain Wilson, Professor of Microbiology and Immunology at URMC, the next step is to determine the level of protection provided by cross-reactive memory B cells and how it impacts patient outcomes. “Now we need to see if having this pool of pre-existing memory B cells correlates with milder symptoms and shorter disease course, or if it helps boost the effectiveness of COVID-19 vaccines.”

This is research that biomedical sector players like VistaGen Therapeutics Inc. (NASDAQ: VTGN) are likely to follow since it suggests that the COVID-19 problem may not be such a long-term threat as had been originally thought.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, October 8th, 2020 Uncategorized Comments Off on $VTGN Seasonal Colds Could Offer Protection Against COVID-19

$SGTM Secures Additional Mulch Contracts from Large Commercial Chain

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary, Mulch Manufacturing Inc., has obtained 2021 mulch contracts from three Circle K convenience store divisions, a subsidiary of Alimentation Couche-Tard Inc. (OTC: ANCUF). This follows after the company secured a mulch and soil purchase agreement with The Kroger Company (NYSE: KR). “Obtaining three Circle K convenience store’s mulch contracts for 2021 gives us an amazing opportunity to build a relationship with their brand and expand throughout more stores,” SGTM’s CEO and Director Tony Raynor said in the news release. “We have been blessed to be offered these amazing opportunities from large chain accounts to help further expand our brand and overall exposure.”

To view the full press release, visit: https://nnw.fm/ajPVI

About Sustainable Green Team Ltd.

Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential, and commercial clients. For information regarding SGTM’s operations, expansion plans and production facilities, visit http://nnw.fm/3iVHn

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://nnw.fm/SGTM

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Thursday, October 8th, 2020 Uncategorized Comments Off on $SGTM Secures Additional Mulch Contracts from Large Commercial Chain

$WTER Announces Board Appointment of Seasoned Retail Veteran

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of directors, effective Oct. 8, 2020. Lazaran will serve on the company’s audit and compensation committees. Simultaneous to the appointment, Bruce Leitch has decided to step down from the company’s board of directors to focus on other business endeavors. “On behalf of the board, we are delighted to welcome Frank Lazaran as a full-time member of The Alkaline Water Company’s Board of Directors,” WTER Chairman of the Board Aaron Keay said in the news release. “Frank is a seasoned industry veteran with experience and knowledge that will be instrumental as we scale our growing lifestyle brands to existing and new trade channels. Also, we want to thank Bruce for his outstanding leadership and guidance since 2016. His various contributions have helped to drive growth and innovation for our core brand, Alkaline88(R), and our emerging portfolio of A88 Infused(TM) and A88CBD(TM) products.”

To view the full press release, visit http://cnw.fm/pDIvC

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Thursday, October 8th, 2020 Uncategorized Comments Off on $WTER Announces Board Appointment of Seasoned Retail Veteran

$VTGN Is ‘One to Watch’

VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Based out of South San Francisco, California, the “Birthplace of Biotechnology,” VistaGen is headquartered among the largest cluster of biotechnology companies in the world. A recent article discussing the company reads, “VistaGen currently has three innovative CNS drug candidates in its pipeline: PH94B, PH10 and AV-101. With a differentiated mechanism of action and an exceptional safety profile in all clinical studies to date, each of VistaGen’s three drug candidates offers significant commercialization potential in multiple large CNS markets.”

To view the full article, visit: https://ibn.fm/N9ZB3

About VistaGen

VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $VTGN Is ‘One to Watch’

$SRAX Announces Acquisition of Micro-Cap Specialist Data Company, LD Micro

  • SRAX has announced acquisition of LD Micro, a leading data company serving small and micro-cap listed company space
  • SRAX will pay gross consideration of 1.6 million new SRAX shares along with four $1 million installments
  • Following acquisition, LD Micro will be wholly-owned subsidiary of SRAX and will continue to employ Christopher Lahiji, its founder, as president
  • Christopher Lahiji has also been named to SRAX Board of Directors

SRAX (NASDAQ: SRAX), a financial technology company focused on unlocking data and insights for publicly traded companies through Sequire, its SaaS platform, announced that it had recently closed the acquisition of LD Micro, a leading data and event company serving the small and micro-cap space (https://nnw.fm/BhE2C). SRAX will pay a total consideration of 1.6 million new Class A SRAX common shares to LD Micro’s shareholders, which will be subject to a 36-month lock-up in addition to four quarterly installments of $1 million, with the first payment made upon the closing of the acquisition.

LD Micro was founded in 2006 with the purpose of providing investors with an independent resource into the listed micro-cap space. What started out as a newsletter highlighting unique companies eventually transformed into several influential events, which have firmly entrenched themselves as must-attend occasions for members of the listed micro-cap universe and institutional investors alike. Separately, LD Micro also launched ldmicro.com, a portal providing exclusive intraday information on the entire sector, including the first pure micro-cap index (LDMi) which covers stocks in North America boasting market capitalizations between $50 million to $300 million.

In early September, LD Micro held its flagship Main Event conference, which attracted over 1,500 delegates and hosted close to 300 innovative companies derived from a variety of sectors, including technology, biotech, pharmaceuticals, and alternative energy among various others. In illustration of the considerable breadth of the company’s flagship conference, the event featured a number of keynote addresses focused around noteworthy updates within the IPO market for North American microcaps.  Discussions centered around the evolution of cryptocurrency as well updates from the Securities & Exchange Commission on recent regulatory developments within the listed microcap equity universe.

Following the acquisition, LD Micro will become a wholly-owned subsidiary of SRAX and will continue to employ Christopher Lahiji, its founder, as president. Mr. Lahiji has also been appointed to the board of directors of SRAX.

A more comprehensive description of the terms and conditions of the transaction is disclosed, and copies of the transaction documents are filed, in the Company’s current report on Form 8-K filed with the Securities Exchange Commission on September 11, 2020, which is available on the Company’s website and at www.SEC.gov.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $SRAX Announces Acquisition of Micro-Cap Specialist Data Company, LD Micro

$SGLB What Are The Best Penny Stocks Today? 4 For Your Watch List

It doesn’t matter if you’re looking at small cap penny stocks or larger cap ones, if they’re trending, someone’s watching. The name of the game with these cheap stocks is simple: make money quickly. Some choose to map out a strategy for day trading and scalping while others focus on longer-term swing trading or even investing in penny stocks . It’s important to understand that if you’re looking to navigate these volatile waters, a strategy is important.

This is why I mention mapping out how you’re going to approach a trade or investment. The fact of the matter is that these mostly small cap stocks are known to shift direction quickly. As such, your strategy could dictate how you put together your penny stocks list to watch. If you’re a day trader or scalper, you’re likely looking for stocks that are experiencing higher levels of volatility.

However, if you’re looking more long term then you’ll want to focus on penny stocks with a more established trend and companies with stronger fundamentals. Now, not all penny stocks are going to “play out” to your plan’s design. However, taking the time to do your research can help put a sound list of penny stocks together. Then it’s up to the market to decide what’s next.

Obviously, when it comes to things like pre market penny stocks gapping up , everything can change right at the opening bell. In that case, prudent traders might wait to see how the first 15-30 minutes of a trading session pans out. Heading into the second half of the week, there are several penny stocks trading higher. Will they be on your buy or sell list?

Penny Stocks To Buy [or sell]: CVD Equipment Corp

Shares of CVD Equipment Corp. ( CVV Stock Report ) were trending much higher on Wednesday. It wasn’t much of a hype-spike as it was a consistent move higher. From the opening bell to its initial lunch time high, CVV stock rallied from $3 to $5.25. There weren’t any news headlines to pair with the move. However, we have seen a lot of attention placed on industrials stocks moving in the stock market today.

Read More

CVD focuses on a broad range of chemical vapor deposition, gas control, and other equipment to develop and manufacture materials and coatings. This equipment is used for aerospace engine components, medical implants, semiconductors, solar cells, smart glass among other applications.

WIth stocks like PECK, PPSI, SPI, SUNW and many others soaring today, CVV stock could be gaining some sympathy amid industrials this week. It mirrors some of the similarities from share structure as the stocks I just mentioned. Namely, it’s a low float industrial penny stock to watch. Given this, CVV could also be one of the more volatile names on this list. In light of that, be well aware that this could swing in either direction aggressively so keep your strategy in mind.

penny stocks to buy sell CVD Equipment Corp. (CVV stock chart)

Penny Stocks To Buy [or sell]: ReneSola

RenaSola ( SOL Stock Report ) is another one of the industrials penny stocks gaining on sympathy momentum this week. In fact, for the better part of the last few months, SOL stock has managed to hold a relatively clear uptrend. But as I’m sure you’ll see, the penny stock’s ups and downs are very much a thing to assess if this is on your list of penny stocks to watch. Since Monday, SOL stock has jumped over 75% alone and volume has surged.

While it isn’t as low float a penny stock as the others, the company has responded similarly with surging momentum amid this latest sympathy move. Something to note, however, is that the company has also come out with some news of its own within the last few weeks.

At the end of September, the solar project developer agreed to form a joint venture with Munich, Germany-based Vodasun. The two will co-develop and market ready-to-build ground-mounted solar projects in Germany. This venture will have an initial project portfolio of 50 to 100 megawatts. There’s also a target of another 50 to 100 megawatts of new projects per year. With such a massive swing higher this week, can SOL stock maintain at these higher levels or is it set to sell-off before the end of the week?

penny stocks to buy sell ReneSola (SOL stock chart)

Penny Stocks To Buy [or sell]: Checkpoint Therapeutics

What list of penny stocks would be complete without some biotech stocks ? Checkpoint Therapeutics Inc. ( CKPT Stock Report ) has been able to experience a nice technical move over the last few weeks. Shares pulled back from recent $4.50 highs after the company announced a $20 million raise in mid-September. Finally finding some support along its 50-day moving average, CKPT stock held a sideways trend for the bulk of September’s second half. However, as October has begun, so to appears to be a slight uptrend in the penny stock. On October 7th, shares bounced to highs of $2.82 during the mid-afternoon session.

[Read More] 5 Penny Stocks To Buy, Sell, Or Hold Right Now According To Analysts

Volume isn’t as heavy as it has been in the past. However, CKPT stock has managed to mount a recovery so far. The company was founded by Fortress Biotech ( FBIO Stock Report ) has followed the trend in cancer and immunotherapy stocks we’ve seen recently. Checkpoint develops, acquires, and commercializes non-chemotherapy, combination treatments. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX).

The company’s last update on its ongoing Phase 1 trials showed meaningful results according to the company. The trial studies its cosibelimab treatment, in patients with advanced cancers. Checkpoint explained that cosibelimab “demonstrated a 51.4% objective response rate and 13.5% complete response rate, which is nearly double the complete response rate observed at the time of previous analysis.”

penny stocks to buy sell Checkpoint Therapeutics Inc. (CKPT stock chart)

Penny Stocks To Buy [or sell]: Sigma Labs Inc.

Sigma Labs Inc. ( SGLB Stock Report ) is another one of the top trending penny stocks to watch recently. The company hit the radar back in August after the company announced the award of a contract by Mitsubishi Heavy Industries. Sigma will implement PrintRite3D® in-process quality assurance software.

One of the other trends we’re seeing in the stock market today is in 3D printing believe it or not. Companies like 3D Systems Inc. ( DDD Stock Report ) and Stratasys ( SSYS Stock Report ) gained traction on Wednesday. Whether or not this is a sympathy-type move is yet to be seen. However, SGLB stock has pushed higher during Wednesday’s session on higher volume.

In addition to Mitsubishi, Sigma announced earlier this week that it launched its newest product, the PrintRite3D Lite In-Process Quality Assurance system. Furthermore, it was awarded its first contract from Coherent, Inc. ( COHR Stock Report ). Coherent is one of the world’s top providers of lasers and laser-based technology for scientific, commercial, and industrial customers.

penny stocks to buy sell Sigma Labs Inc. (SGLB stock chart)
Wednesday, October 7th, 2020 Uncategorized Comments Off on $SGLB What Are The Best Penny Stocks Today? 4 For Your Watch List

$PCSA Announces Closing of Public Offering

Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on the development of drug products intended to provide treatment for and improve the survival and/or quality of life of patients who have a high unmet medical need condition or who have no alternative treatment, announced that the public offering resulted in gross proceeds of approximately $19.2 million. PCSA has filed a registration statement relating to the securities being sold with the Securities and Exchange Commission (“SEC”); the filing was effective on Oct. 1, 2020. A final prospectus has also been filed with the SEC. Copies of the final prospectus may be obtained from the Craig-Hallum Capital Group, which acted as joint book-running managers for the offering, along with The Benchmark Company. National Securities Corporation acted as co-manager for the offering.

To view the full press release, visit http://ibn.fm/0thEx

About Processa Pharmaceuticals Inc.

The mission of Processa has been to develop products where existing clinical evidence of efficacy already exists in unmet medical need conditions, medical conditions where patients need treatment options that will improve survival and/or quality of life. The company has assembled a proven regulatory science development team, management team and Board of Directors. The Processa development team has been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and 100 FDA meetings. For more information, visit www.ProcessaPharmaceuticals.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at http://ibn.fm/PCSA

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $PCSA Announces Closing of Public Offering

$NETE Is it Dangerous to Charge Your EV in the Rain?

It is a well-known fact that electricity and water do not go well together. Most electronics shouldn’t be put in water and manufacturers constantly caution consumers against using their electronics in or near a wet environment. And for the most part, it’s not that hard to keep your toaster, television, or hairdryer away from water. But what if you are driving an electric vehicle (“EV”) and have to charge in the rain?

Electric vehicles are set to phase out internal combustion vehicles over the next decade or two. Although the technology behind EVs is decades old, the industry is still relatively new, and prospective customers as well as those who are just curious have plenty of questions. If you are thinking of purchasing an EV, the thought of running out of charge on a rainy day may have crossed your mind.

And if you paid attention to your parents and teachers as a child, you’re probably wary of going out into the soaking rain and plugging your electric vehicle into a charger. Maybe you’ll be electrocuted, maybe the car will explode: the possibilities seem endless. However, electric vehicle manufacturers took this into consideration, and consequently, most if not all EVs on the market can indeed be charged in the rain.

According to Jonathan Ratliff, Nissan North America’s senior manager for zero-emission technology development, he has heard this question “many many times” while spending years working on zero-emission vehicles. Because electric vehicles are purposefully engineered to withstand rain and water intrusion as well as dust particles that could wreak havoc on the electric system, he says, “it is safe to charge in nearly any weather condition.”

Like most items used in daily life like smartphones, wall outlets, and kitchen appliances, electric vehicles are subject to an Ingress Protection Rating, usually expressed in two digits. The first digit relates to small objects like dust particles or dirt while the second relates to protection against water and liquids. Ratcliff states that the rating scale for dust/solid object protection extends from 1-6, with 6 being the best protection while the scale for liquids ranges from 1-8, with 8 being the highest protection.

“An IP rating for 8 would be submersible and oceanic equipment, something underwater for a long, long time. Buoys are typically what you get in an 8 rating,” he says. The Nissan Leaf, for instance, has an IP rating of 67 and according to Ratliff, that is equivalent “to submerging any component of our vehicle in water at 1 meter for 30 minutes.” If the EV can withstand this level of submersion for up to thirty minutes, you can be sure it can withstand a little rainfall while it charges. It is no wonder that entities like Net Element (NASDAQ: NETE) are in full support of switching to electric vehicles since every possible precaution to keep them safe was taken by manufacturers.

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $NETE Is it Dangerous to Charge Your EV in the Rain?

$GNPX CEO Scheduled to Present at LD Micro Event

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, is slated to present at an upcoming LD Micro virtual event. GNPX’s Zoom presentation is scheduled for Wednesday, Oct. 14, at 11 a.m. ET. The presentation will feature Genprex president and CEO Rodney Varner, who will deliver a corporate presentation and then participate in a Q&A. Investors and others interested in viewing the presentation can register at https://ibn.fm/MiDEy.

To view the full press release, visit http://ibn.fm/RdBSZ

About Genprex Inc.

Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, GPX-001 (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $GNPX CEO Scheduled to Present at LD Micro Event

$DRIO Heading Soccer Balls Causes More Damage to Females than Males

Today, it is common to see members of a female soccer team training close to the ground that is being used by their male counterparts, and this is pleasing given how far society has come before accepting that females can participate in contact sports. However, lots of sports scientists noticed that females were complaining more about the effects of heading the ball when compared to their male counterparts. It now turns out that there is a scientific reason for that as explored below.

According to a study that was led by Dr. Michael Lipton, a neuroscientist based at the Albert Einstein College of Medicine, women suffer five times the amount of brain damage as males who head the ball during soccer games. The study also found that women take longer to recover from the resultant injuries sustained during sports.

The research team used MRI scans to take a look into the brains of 98 amateur soccer players, all of them adults. Half of them were male while the other half were female. These study subjects were selected on the basis of having headed the ball multiple times within the past year.

The scans done on the female soccer players showed some structural deterioration in eight white matter regions involved in carrying signals from one part of the brain to another. However, the male soccer players only had damage in three white matter regions. For both genders, the number of affected regions increased with an increase in the frequency of heading the ball.

When the volume of damaged brain tissue was analyzed, it was found that the female players suffered damage in about 2,100 cubic millimeters of the brain’s tissues while males only suffered damage in approximately 400 cubic millimeters.

The research team wasn’t sure why these sex differences exist regarding athletes heading the ball. However, they speculate that two factors could be at play.

First, Dr. Lipton and his team suggest that since women have less muscle mass to protect their heads from cranial impacts, they tend to suffer higher degrees of whiplash each time they head the ball.

Secondly, women could suffer more inflammation in the brain if they head the ball at the time in their menstrual cycles when progesterone is low. Progesterone is known to protect against brain inflammation, so a dip in this hormone makes females more susceptible to intracranial injuries each time they head the ball.

The research team is now interested in finding out whether the damage suffered while heading the ball is linked to any long-term cognitive effects. In the meantime, experts think biomedical companies like DarioHealth Corp. (NASDAQ: DRIO) would recommend taking any protective measures necessary to avert as many of those intracranial injuries as possible during soccer games.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, October 7th, 2020 Uncategorized Comments Off on $DRIO Heading Soccer Balls Causes More Damage to Females than Males

$BHAT Further Strengthens Market Presence in Education Sector

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced a strategic collaboration. According to the update, Fujian Youth Hand in Hand Educational Technology Co. Ltd, a joint venture Blue Hat formed with a third party (“Fujian Youth” or the “JV”) and Guangzhou Tongsheng Education Technology Ltd. (“Tongsheng Education”) have reached an agreement to provide Augmented Reality Immersive Classes (“ARIC”) in Guangzhou over a three-year period. The JV will partner with Tongsheng Education with a goal to launch ARIC in a total of 320 preschools (20 the first year, 100 the second year and 200 the third year) in Guangzhou over a course of three years. The move begins Blue Hat’s strategic expansion in the Guangdong -Hong Kong-Macao Greater Bay Area (the “Greater Bay Area”). “This agreement allows us to further strengthen our market presence in the education sector, which along with augmented reality toys and games, are the three main pillars of Blue Hat’s business model,” BHAT CEO Xiaodong Chen said in the news release. “Our ARIC products have been well received since they were introduced to the market. At present, we have actively promoted them in Guangxi, Guangdong and other provinces and continue to build market share and expand our markets geographically. This cooperation provides a solid foundation for continued marketing efforts in the Greater Bay Area. With the continued development of education informatization in the Greater Bay Area and the growing demand for innovative teaching, we are confident to complete the goal of delivering ARIC services to 320 Guangzhou preschools in three years.”

To view the full press release, visit: https://nnw.fm/3oiQU

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile-game features. The company’s entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the company’s investor relations website at www.IR.BlueHatGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Wednesday, October 7th, 2020 Uncategorized Comments Off on $BHAT Further Strengthens Market Presence in Education Sector

Rritual Mushrooms Inc. Engages InvestorBrandNetwork

Rritual Mushrooms, a premium brand in the emerging functional mushroom market, has announced that it has selected InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, for its communication needs. Founded in 2019, Rritual Mushrooms is a private company with a declared purpose to help people meet the demands of modern life with style and ease by incorporating functional mushrooms, adaptogens and superfoods into their diets. Rritual Mushrooms engaged IBN to leverage its investor-based distribution network of more than 5,000 key syndication outlets, social media channels, wire services and more to tell the Rritual story. That story includes Rritual’s ability to manufacture premium plant-based products such as small-batch elixir powders and meet the needs of customers from every lifestyle. “As it is yet in its early stages, the functional mushrooms market is rife with opportunities for growth,” said IBN director of client solutions Chris Johnson in the press release. “Although the global functional mushroom market is expected to exceed $50 billion by 2025, there remains an absence of a premium brand to lead the category. We’re excited to customize our comprehensive suite of corporate communications solutions for Rritual as it looks to capitalize on this opportunity.”

To view the full press release, visit https://nnw.fm/fLV6f

About Rritual Mushrooms Inc.

Launched in 2019, Rritual makes premium, plant-based elixir products in small batches featuring mindfully selected medicinal mushrooms and adaptogenic herbs. To help support and achieve an optimal need-state, Rritual offers a range of products to fit every lifestyle. Rritual produces simple mushroom adaptogen products with limited, yet very purposeful and organic ingredients. For more information about the company, visit www.WeAreRritual.com. 

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at https://nnw.fm/Rritual

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Wednesday, October 7th, 2020 Uncategorized Comments Off on Rritual Mushrooms Inc. Engages InvestorBrandNetwork